| Year |
Citation |
Score |
| 2015 |
Mascarenhas R, Pietrzak M, Smith RM, Webb A, Wang D, Papp AC, Pinsonneault JK, Seweryn M, Rempala G, Sadee W. Allele-Selective Transcriptome Recruitment to Polysomes Primed for Translation: Protein-Coding and Noncoding RNAs, and RNA Isoforms. Plos One. 10: e0136798. PMID 26331722 DOI: 10.1371/Journal.Pone.0136798 |
0.536 |
|
| 2015 |
Lu R, Smith RM, Seweryn M, Wang D, Hartmann K, Webb A, Sadee W, Rempala GA. Analyzing allele specific RNA expression using mixture models. Bmc Genomics. 16: 566. PMID 26231172 DOI: 10.1186/S12864-015-1749-0 |
0.547 |
|
| 2015 |
Handelman SK, Seweryn M, Smith RM, Hartmann K, Wang D, Pietrzak M, Johnson AD, Kloczkowski A, Sadee W. Conditional entropy in variation-adjusted windows detects selection signatures associated with expression quantitative trait loci (eQTLs). Bmc Genomics. 16: S8. PMID 26111110 DOI: 10.1186/1471-2164-16-S8-S8 |
0.518 |
|
| 2014 |
Di Giorgio A, Smith RM, Fazio L, D'Ambrosio E, Gelao B, Tomasicchio A, Selvaggi P, Taurisano P, Quarto T, Masellis R, Rampino A, Caforio G, Popolizio T, Blasi G, Sadee W, et al. DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory. Plos One. 9: e95997. PMID 24819610 DOI: 10.1371/Journal.Pone.0095997 |
0.52 |
|
| 2014 |
Smith RM, Banks W, Hansen E, Sadee W, Herman GE. Family-based clinical associations and functional characterization of the serotonin 2A receptor gene (HTR2A) in autism spectrum disorder. Autism Research : Official Journal of the International Society For Autism Research. 7: 459-67. PMID 24753316 DOI: 10.1002/Aur.1383 |
0.55 |
|
| 2013 |
Grevel J, Thomas J, Richards ML, Sadée W. Radioreceptor assay of narcotic analgesics in serum. Pharmaceutical Research. 1: 209-14. PMID 24277330 DOI: 10.1023/A:1016369229440 |
0.31 |
|
| 2013 |
Richards ML, Sadée W. Buprenorphine is an Antagonist at the ϰ Opioid Receptor. Pharmaceutical Research. 2: 178-81. PMID 24272810 DOI: 10.1023/A:1016340106299 |
0.339 |
|
| 2013 |
Smith RM, Webb A, Papp AC, Newman LC, Handelman SK, Suhy A, Mascarenhas R, Oberdick J, Sadee W. Whole transcriptome RNA-Seq allelic expression in human brain. Bmc Genomics. 14: 571. PMID 23968248 DOI: 10.1186/1471-2164-14-571 |
0.53 |
|
| 2013 |
Smith RM, Papp AC, Webb A, Ruble CL, Munsie LM, Nisenbaum LK, Kleinman JE, Lipska BK, Sadee W. Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex. Biological Psychiatry. 73: 546-54. PMID 23158458 DOI: 10.1016/J.Biopsych.2012.09.028 |
0.577 |
|
| 2012 |
Barrie ES, Smith RM, Sanford JC, Sadee W. mRNA transcript diversity creates new opportunities for pharmacological intervention. Molecular Pharmacology. 81: 620-30. PMID 22319206 DOI: 10.1124/Mol.111.076604 |
0.528 |
|
| 2011 |
Smith RM, Sadee W. Synaptic signaling and aberrant RNA splicing in autism spectrum disorders. Frontiers in Synaptic Neuroscience. 3: 1. PMID 21423409 DOI: 10.3389/Fnsyn.2011.00001 |
0.511 |
|
| 2011 |
Sadee W, Wang D, Papp AC, Pinsonneault JK, Smith RM, Moyer RA, Johnson AD. Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy. Clinical Pharmacology and Therapeutics. 89: 355-65. PMID 21289622 DOI: 10.1038/Clpt.2010.314 |
0.534 |
|
| 2011 |
Moyer RA, Wang D, Papp AC, Smith RM, Duque L, Mash DC, Sadee W. Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 753-62. PMID 21150907 DOI: 10.1038/Npp.2010.208 |
0.528 |
|
| 2011 |
Smith RM, Alachkar H, Papp AC, Wang D, Mash DC, Wang JC, Bierut LJ, Sadee W. Nicotinic α5 receptor subunit mRNA expression is associated with distant 5' upstream polymorphisms. European Journal of Human Genetics : Ejhg. 19: 76-83. PMID 20700147 DOI: 10.1038/Ejhg.2010.120 |
0.549 |
|
| 2009 |
Roe BE, Tilley MR, Gu HH, Beversdorf DQ, Sadee W, Haab TC, Papp AC. Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene. Plos One. 4: e6704. PMID 19693267 DOI: 10.1371/Journal.Pone.0006704 |
0.516 |
|
| 2008 |
Johnson AD, Zhang Y, Papp AC, Pinsonneault JK, Lim JE, Saffen D, Dai Z, Wang D, Sadée W. Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Pharmacogenetics and Genomics. 18: 781-91. PMID 18698231 DOI: 10.1097/Fpc.0B013E3283050107 |
0.506 |
|
| 2007 |
Lim JE, Pinsonneault J, Sadee W, Saffen D. Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons. Molecular Psychiatry. 12: 491-501. PMID 17453063 DOI: 10.1038/sj.mp.4001923 |
0.496 |
|
| 2006 |
Lim JE, Papp A, Pinsonneault J, Sadée W, Saffen D. Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. Molecular Psychiatry. 11: 649-62. PMID 16432527 DOI: 10.1038/sj.mp.4001797 |
0.485 |
|
| 2003 |
Han G, Quillan JM, Carlson K, Sadée W, Hruby VJ. Design of novel chimeric melanotropin-deltorphin analogues. Discovery of the first potent human melanocortin 1 receptor antagonist. Journal of Medicinal Chemistry. 46: 810-9. PMID 12593660 DOI: 10.1021/Jm020355O |
0.348 |
|
| 2002 |
Botka CW, Wittig TW, Graul RC, Nielsen CU, Higaka K, Amidon GL, Sadée W. Human proton/oligopeptide transporter (POT) genes: identification of putative human genes using bioinformatics. Aaps Pharmsci. 2: E16. PMID 11741232 DOI: 10.1208/Ps020216 |
0.301 |
|
| 2001 |
Lucas JL, DeYoung JA, Sadee W. Single nucleotide polymorphisms of the human M1 muscarinic acetylcholine receptor gene Aaps Pharmsci [Electronic Resource]. 3: E31. PMID 12049494 DOI: 10.1208/Ps030431 |
0.352 |
|
| 2001 |
Sadee W, Hoeg E, Lucas J, Wang D. Genetic variations in human G protein-coupled receptors: implications for drug therapy. Aaps Pharmsci. 3: E22. PMID 11741273 DOI: 10.1208/Ps030322 |
0.378 |
|
| 2001 |
Wang D, Quillan JM, Winans K, Lucas JL, Sadée W. Single nucleotide polymorphisms in the human mu opioid receptor gene alter basal G protein coupling and calmodulin binding. The Journal of Biological Chemistry. 276: 34624-30. PMID 11457836 DOI: 10.1074/Jbc.M104083200 |
0.375 |
|
| 2001 |
Wang D, Raehal KM, Bilsky EJ, Sadée W. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence. Journal of Neurochemistry. 77: 1590-600. PMID 11413242 DOI: 10.1046/J.1471-4159.2001.00362.X |
0.334 |
|
| 2001 |
Graul RC, Sadee W. Evolutionary relationships among G protein-coupled receptors using a clustered database approach Aaps Pharmsci. 3. DOI: 10.1208/Ps030212 |
0.32 |
|
| 2000 |
Wang D, Tolbert LM, Carlson KW, Sadée W. Nuclear Ca2+/calmodulin translocation activated by mu-opioid (OP3) receptor. Journal of Neurochemistry. 74: 1418-25. PMID 10737597 DOI: 10.1046/J.1471-4159.2000.0741418.X |
0.342 |
|
| 2000 |
Wang Z, Sadée W. Tolerance to morphine at the mu-opioid receptor differentially induced by cAMP-dependent protein kinase activation and morphine. European Journal of Pharmacology. 389: 165-71. PMID 10688980 DOI: 10.1016/S0014-2999(99)00881-X |
0.338 |
|
| 2000 |
Choi DS, Wang D, Tolbert L, Sadée W. Basal signaling activity of human dopamine D2L receptor demonstrated with an ecdysone-inducible mammalian expression system Journal of Neuroscience Methods. 94: 217-225. PMID 10661841 DOI: 10.1016/S0165-0270(99)00147-8 |
0.348 |
|
| 1999 |
Shockley MS, Tolbert LM, Tobin AB, Nahorski SR, Sadée W, Lameh J. Differential regulation of muscarinic M1 and M3 receptors by a putative phosphorylation domain. European Journal of Pharmacology. 377: 137-46. PMID 10448936 DOI: 10.1016/S0014-2999(99)00303-9 |
0.314 |
|
| 1999 |
Wang D, Sadée W, Quillan JM. Calmodulin binding to G protein-coupling domain of opioid receptors. The Journal of Biological Chemistry. 274: 22081-8. PMID 10419536 DOI: 10.1074/Jbc.274.31.22081 |
0.377 |
|
| 1999 |
Ito K, Haga T, Lameh J, Sadée W. Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. European Journal of Biochemistry. 260: 112-9. PMID 10091590 DOI: 10.1046/J.1432-1327.1999.00125.X |
0.344 |
|
| 1998 |
Quillan JM, Sadée W, Wei ET, Jimenez C, Ji L, Chang JK. A synthetic human Agouti-related protein-(83-132)-NH2 fragment is a potent inhibitor of melanocortin receptor function. Febs Letters. 428: 59-62. PMID 9645475 DOI: 10.1016/S0014-5793(98)00487-6 |
0.313 |
|
| 1998 |
Burford NT, Tolbert LM, Sadee W. Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin I. European Journal of Pharmacology. 342: 123-6. PMID 9544801 DOI: 10.1016/S0014-2999(97)01556-2 |
0.328 |
|
| 1998 |
Tsuga H, Kameyama K, Haga T, Honma T, Lameh J, Sadée W. Internalization and down-regulation of human muscarinic acetylcholine receptor m2 subtypes. Role of third intracellular m2 loop and G protein-coupled receptor kinase 2. The Journal of Biological Chemistry. 273: 5323-30. PMID 9478991 DOI: 10.1074/Jbc.273.9.5323 |
0.367 |
|
| 1998 |
Lu YF, Xu H, Liu-Chen LY, Chen C, Partilla JS, Brine GA, Carroll FI, Rice KC, Lai J, Porreca F, Sadee W, Rothman RB. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor. Synapse (New York, N.Y.). 28: 117-24. PMID 9450512 DOI: 10.1002/(Sici)1098-2396(199802)28:2<117::Aid-Syn2>3.0.Co;2-E |
0.369 |
|
| 1997 |
Shockley MS, Burford NT, Sadée W, Lameh J. Residues specifically involved in down-regulation but not internalization of the m1 muscarinic acetylcholine receptor. Journal of Neurochemistry. 68: 601-9. PMID 9003046 DOI: 10.1046/J.1471-4159.1997.68020601.X |
0.348 |
|
| 1996 |
Bilsky EJ, Inturrisi CE, Sadée W, Hruby VJ, Porreca F. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective μ or δ opioid agonists in mice Pain. 68: 229-237. PMID 9121809 DOI: 10.1016/S0304-3959(96)03185-5 |
0.31 |
|
| 1996 |
Wang Z, Arden J, Sadée W. Basal phosphorylation of mu opioid receptor is agonist modulated and Ca2+-dependent. Febs Letters. 387: 53-7. PMID 8654566 DOI: 10.1016/0014-5793(96)00467-X |
0.335 |
|
| 1995 |
Kameyama K, Haga K, Haga T, Moro O, Sadée W. Activation of a GTP-binding protein and a GTP-binding-protein-coupled receptor kinase (beta-adrenergic-receptor kinase-1) by a muscarinic receptor m2 mutant lacking phosphorylation sites. European Journal of Biochemistry. 226: 267-76. PMID 8001544 DOI: 10.1111/J.1432-1033.1994.Tb20050.X |
0.341 |
|
| 1995 |
Sadée W, Wang Z. Agonist induced constitutive receptor activation as a novel regulatory mechanism. Mu receptor regulation. Advances in Experimental Medicine and Biology. 373: 85-90. PMID 7668164 DOI: 10.1007/978-1-4615-1951-5_12 |
0.369 |
|
| 1995 |
Shockley M, Högger P, Lameh J, Sadée W. Identification of residues in the intracellular loops of the human muscarinic cholinergic HM1 receptor involved in G-protein coupling and down-regulation Life Sciences. 56: 1030. DOI: 10.1016/0024-3205(95)93772-7 |
0.32 |
|
| 1994 |
Wang Z, Bilsky EJ, Porreca F, Sadee W. Constitutive μ opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence Life Sciences. 54. PMID 7514710 DOI: 10.1016/0024-3205(94)90022-1 |
0.33 |
|
| 1994 |
Wang Z, Arden JR, Segredo V, Sadée W. Agonist induced constitutive activation of the μ opioid receptor by phosphorylation Regulatory Peptides. 54: 323-324. DOI: 10.1016/0167-0115(94)90519-3 |
0.36 |
|
| 1994 |
Wang Z, Sadée W. Constitutive μ opioid receptor activity in human neuroblastoma SK-N-SH cells Regulatory Peptides. 53: S283-S284. DOI: 10.1016/0167-0115(94)90348-4 |
0.357 |
|
| 1993 |
Drübbisch V, Lameh J, Philip M, Sharma YK, Sadée W. Mapping the ligand binding pocket of the human muscarinic cholinergic receptor Hm1: contribution of tyrosine-82. Pharmaceutical Research. 9: 1644-7. PMID 1488411 DOI: 10.1023/A:1015885029612 |
0.33 |
|
| 1992 |
Cook JS, Wolsing DH, Lameh J, Olson CA, Correa PE, Sadee W, Blumenthal EM, Rosenbaum JS. Characterization of the RDC1 gene which encodes the canine homolog of a proposed human VIP receptor. Expression does not correlate with an increase in VIP binding sites. Febs Letters. 300: 149-52. PMID 1373390 DOI: 10.1016/0014-5793(92)80184-I |
0.352 |
|
| 1992 |
Lameh J, Eiger S, Sadée W. Interaction among mu-opioid receptors and alpha 2-adrenoceptors on SH-SY5Y human neuroblastoma cells. European Journal of Pharmacology. 227: 19-24. PMID 1358661 DOI: 10.1016/0922-4106(92)90137-K |
0.308 |
|
| 1992 |
Cone RI, Rosenfeld S, Lameh J, Sadée W. 125I-beta-endorphin binding to neuroblastoma X glioma NG108-15 cells: distribution of delta opioid receptors. Life Sciences. 51: PL219-24. PMID 1331640 DOI: 10.1016/0024-3205(92)90306-A |
0.312 |
|
| 1991 |
Cone RI, Lameh J, Sadée W. Rapid agonist-induced loss of 125I-beta-endorphin opioid receptor sites in NG108-15, but not SK-N-SH neuroblastoma cells. Life Sciences. 49: PL147-52. PMID 1658508 DOI: 10.1016/0024-3205(91)90396-S |
0.347 |
|
| 1991 |
Maeda S, Lameh J, Philip M, Sadee W. Functions of the third cytoplasmic loop of human m1 muscarinic cholinergic receptors : Receptor internalization and phosphatidyl inositol turnover Neuroscience Research Supplements. 14: S136. DOI: 10.1016/S0921-8696(06)80397-X |
0.33 |
|
| 1990 |
Maeda S, Lameh J, Mallet WG, Philip M, Ramachandran J, Sadée W. Internalization of the Hm1 muscarinic cholinergic receptor involves the third cytoplasmic loop. Febs Letters. 269: 386-8. PMID 2401364 DOI: 10.1016/0014-5793(90)81199-X |
0.344 |
|
| 1990 |
Lameh J, Cone RI, Maeda S, Philip M, Corbani M, Nádasdi L, Ramachandran J, Smith GM, Sadée W. Structure and function of G protein coupled receptors. Pharmaceutical Research. 7: 1213-21. PMID 1965663 DOI: 10.1023/A:1015969301407 |
0.319 |
|
| 1990 |
Yu VC, Eiger S, Duan DS, Lameh J, Sadée W. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells. Journal of Neurochemistry. 55: 1390-6. PMID 1697894 DOI: 10.1111/J.1471-4159.1990.Tb03151.X |
0.346 |
|
| 1988 |
Hochhaus G, Sadée W. A Biotin–Avidin-Based Enzyme Immunoassay for βh-Endorphin Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 5: 232-235. PMID 2977649 DOI: 10.1023/A:1015993713471 |
0.504 |
|
| 1988 |
Hochhaus G, Patthy A, Schwietert R, Santi DV, Sadée W. [Biocytin13]Dynorphin A 1-13 Amide: A Potential Probe for the κ-Opioid Receptor Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 5: 790-794. PMID 2907785 DOI: 10.1023/A:1015944903360 |
0.573 |
|
| 1988 |
Sadee W, Yu VC, Hochhaus G. Effects of opioid peptides on human neuroblastoma cells Nida Research Monograph Series. 111-117. PMID 2855093 |
0.469 |
|
| 1988 |
Preis PN, Saya H, Nadasdi L, Hochhaus G, Levin V, Sadee W. Neuronal Cell Differentiation of Human Neuroblastoma Cells by Retinoic Acid plus Herbimycin A Cancer Research. 48: 6530-6534. PMID 2846152 |
0.451 |
|
| 1988 |
Hochhaus G, Gibson BW, Sadee W. Biotinylated human β-endorphins as probes for the opioid receptor Journal of Biological Chemistry. 263: 92-97. PMID 2826453 |
0.517 |
|
| 1987 |
Yu VC, Sadée W. Phosphatidylinositol turnover in neuroblastoma cells: regulation by bradykinin, acetylcholine, but not mu- and delta-opioid receptors. Neuroscience Letters. 71: 219-23. PMID 3024076 DOI: 10.1016/0304-3940(86)90562-8 |
0.364 |
|
| 1986 |
Lybrand TP, Kollman PA, Yu VC, Sadée W. Conformation and electrostatic potential surfaces of opiates: Relationship to µ- and λ-site binding. Pharmaceutical Research. 3: 218-24. PMID 24271585 DOI: 10.1023/A:1016338730077 |
0.324 |
|
| 1986 |
Richards ML, Sadeé W. In vivo binding of putative delta-selective opioid antagonists to central opiate receptors. European Journal of Pharmacology. 126: 313-6. PMID 3019718 DOI: 10.1016/0014-2999(86)90064-6 |
0.37 |
|
| 1986 |
Hochhaus G, Yu VC, Sadée W. Delta opioid receptor in human neuroblastoma cell lines Brain Research. 382: 327-331. PMID 3019481 DOI: 10.1016/0006-8993(86)91341-7 |
0.557 |
|
| 1986 |
Hochhaus G, Gibson BW, Sadée W. Development of a biotin-avidin probe for detecting opioid receptors Nida Research Monograph. 75: 33-36. PMID 2828982 |
0.488 |
|
| 1985 |
Richards ML, Sadée W. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method. European Journal of Pharmacology. 114: 343-53. PMID 2998812 DOI: 10.1016/0014-2999(85)90379-6 |
0.364 |
|
| 1985 |
Grevel J, Yu V, Sadée W. Characterization of a labile naloxone binding site (lambda site) in rat brain. Journal of Neurochemistry. 44: 1647-56. PMID 2985759 DOI: 10.1111/J.1471-4159.1985.Tb08808.X |
0.306 |
|
| 1984 |
Rosenbaum JS, Holford NH, Sadée W. Opiate receptor binding-effect relationship: sufentanil and etorphine produce analgesia at the mu-site with low fractional receptor occupancy. Brain Research. 291: 317-24. PMID 6320962 DOI: 10.1016/0006-8993(84)91264-2 |
0.315 |
|
| 1984 |
Sadée W, Richards ML, Grevel J, Rosenbaum JS. In vivo characterization of four types of opioid binding sites in rat brain. Life Sciences. 187-9. PMID 6141486 DOI: 10.1016/0024-3205(83)90474-5 |
0.347 |
|
| 1983 |
Rosenbaum JS, Kurowski M, Aman RA, Sadée W. Partial loss of opiate receptor regulation by GPP(NH)P evident in vitro. Life Sciences. 31: 1667-70. PMID 6296568 DOI: 10.1016/0024-3205(82)90181-3 |
0.353 |
|
| 1983 |
Perry DC, Rosenbaum JS, Sadee W. In vivo binding of 3H-etorphine in morphine-dependent rats. Life Sciences. 31: 1405-8. PMID 6292637 DOI: 10.1016/0024-3205(82)90392-7 |
0.355 |
|
| 1983 |
Rosenbaum JS, Sadée W. Demonstration of opiate receptor sub-types in vivo. Life Sciences. 31: 1299-301. PMID 6292617 DOI: 10.1016/0024-3205(82)90366-6 |
0.318 |
|
| 1983 |
Kurowski M, Rosenbaum JS, Perry DC, Sadée W. [3H]-etorphine and [3H]-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate. Brain Research. 249: 345-52. PMID 6291717 DOI: 10.1016/0006-8993(82)90068-3 |
0.346 |
|
| 1982 |
Sadée W, Perry DC, Rosenbaum JS, Herz A. [3H]diprenorphine receptor binding in vivo and in vitro. European Journal of Pharmacology. 81: 431-40. PMID 6288412 DOI: 10.1016/0014-2999(82)90108-X |
0.32 |
|
| 1980 |
Perry DC, Mullis KB, Oie S, Sadée W. Opiate antagonist receptor binding in vivo: evidence for a new receptor binding model. Brain Research. 199: 49-61. PMID 6250676 DOI: 10.1016/0006-8993(80)90229-2 |
0.365 |
|
| 1973 |
CASTAGNOLI N, SADEE W. ChemInform Abstract: MECHANISMEN DER RK. EINES 1,4-BENZODIAZEPIN-N-OXIDES MIT ACETANHYDRID Chemischer Informationsdienst. 4: no-no. DOI: 10.1002/chin.197306283 |
0.409 |
|
| 1972 |
Castagnoli N, Sadée W. Mechanism of the reaction of a 1,4-benzodiazepine N-oxide with acetic anhydride. Journal of Medicinal Chemistry. 15: 1076-8. PMID 5069778 DOI: 10.1021/Jm00280A024 |
0.405 |
|
| 1971 |
Sadèe W, Garland W, Castagnoli N. Microsomal 3-hydroxylation of 1,4-benzodiazepines. Journal of Medicinal Chemistry. 14: 643-5. PMID 5164455 |
0.435 |
|
| 1971 |
SADEE W, GARLAND W, CASTAGNOLI N. ChemInform Abstract: MIKROSOMALE 3-HYDROXYLIERUNG VON 1,4-BENZODIAZEPINEN Chemischer Informationsdienst. Organische Chemie. 2: no-no. DOI: 10.1002/chin.197143360 |
0.388 |
|
| Show low-probability matches. |
